申请人:Ausonia Farmaceutici s.r.l.
公开号:US04634701A1
公开(公告)日:1987-01-06
Compounds of formula (I): ##STR1## wherein: A represents a CH-NO.sub.2 group or a N-CN group; B represents CH.sub.2, O, S or a direct bond; R represents a bicyclic or polycyclic residue, variously substituted and functionalized; R.sup.1 and R.sup.2, which may be the same or different, are hydrogen or C.sub.1 -C.sub.4 alkyl groups; and n and m, which may be the same or different, are 0, 1, 2, 3 or 4; are valuable pharmacological agents.
式(I)的化合物:##STR1## 其中:A代表一个CH-NO.sub.2基团或一个N-CN基团;B代表CH.sub.2、O、S或直接键;R代表一个不同取代和官能化的双环或多环残基;R.sup.1和R.sup.2,可能相同或不同,是氢或C.sub.1-C.sub.4烷基基团;n和m,可能相同或不同,是0、1、2、3或4;这些均是有价值的药理学制剂。